When auto engineers have designs on a new vehicle, they often put the prototype through a computerized gauntlet of digital models and tests before the tires ever hit the pavement. Over the past year, ...

The FINANCIAL — GSK on April 18 opens a £56 million state of the art manufacturing facility, creating 150 new jobs in the UK, in response to demand for GSK’s portfolio of respiratory medicines ...

GlaxoSmithKline said last week that it would back out of antibiotic manufacturing in the U.K., slashing hundreds of jobs in the process. Now, an up-and-coming contract manufacturer is swooping in to ...

GSK plc (NYSE:GSK) on Wednesday announced plans to invest $30 billion across the United States in research and development and supply chain infrastructure over the next five years. The update includes ...

The FINANCIAL — GSK announced a series of investments totalling approximately £200 million that will support the delivery of the company’s pipeline of new medicines and create a centre for ...

RESEARCH TRIANGLE PARK – Drugmaker GlaxoSmithKline has announced $100 million of new investment in its manufacturing site in Montana. The company said it will expand the production capacity at its ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Pennsylvania is providing GSK ...

GSK announced the recent purchase of 235,000 of its ordinary shares, as part of its ongoing share buyback program. The repurchased shares, with a volume-weighted average price of 1,841.56p per share, ...

WALTHAM, Mass., Oct. 1, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has completed its previously announced acquisition of an active ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other best ...

GSK's Exdensur (depemokimab) is now the first FDA-approved, twice-yearly add-on maintenance therapy for severe eosinophilic asthma.